Table 2.
Logistic regression model to predict the occurrence of symptomatic infection in the complete case analysis (n = 98, after list‐wise deletion of patients with one or more missing records on the KIR/HLA system)
| Variable | Code | Adjusted OR (95% CI) | P‐value |
|---|---|---|---|
| GM3/17 | 0: 3/3 (ref.) | ||
| 1: 3/17 | 1·00 (0·26–3·92) | 0·99 n.s. | |
| 2: 17/17 | 20·2 (1·13–359·8) | 0·04 1 | |
| GM23 | 0: −/− (ref.) | ||
| 1: −/+ | 14·53 (1·93–109·58) | 0·009 1 | |
| 2: +/+ | 19·35 (1·7–219·73) | 0·02 1 | |
| KIR2DS2 | 0: absent | ||
| 1: present | 0·14 (0·02–1·16) | 0·07 2 | |
| KIR2DS5 | 0: absent | ||
| 1: present | 8·89 (1·27–61·99) | 0·03 1 | |
| HLA‐C2 | 0: absent | ||
| 1: present | 3·22 (0·88–11·76) | 0·08 2 | |
| HLA‐Bw4T | 0: Absent | ||
| 1: Present | 4·43 (1–19·62) | 0·05 2 |
We report the following degree of evidence against the null hypothesis: 1statistical significance (P < 0·05); 2weak statistical significance (P < 0·10); n.s., not significant. TThreonine.